11.0%$1.42
Revenue Growth Driven by Market Demand
RMD's revenue increased by 11.0% year-over-year to $1.42 billion, primarily due to strong demand in key markets.
Source: Source: 10-Q Income Statement, p.1
AI Takeaway
RMD reported strong financial performance in Q2 FY2026 with significant growth in revenue and net income, driven by increased operational efficiency and robust market demand.
Revenue
$1.42B
++10.98% YoY
EPS (Basic)
$2.69
++14.47% YoY
Gross Margin
61.8%
++3.16% YoY
Operating Income
$491.66M
++17.84% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-Q filing
RMD's revenue increased by 11.0% year-over-year to $1.42 billion, primarily due to strong demand in key markets.
Source: Source: 10-Q Income Statement, p.1
Operating income rose by 17.8% to $491.66 million, reflecting enhanced operational efficiencies and cost management.
Source: Source: 10-Q Income Statement, p.1
Investing cash flow was negative at -$103.52 million due to strategic investments in growth initiatives.
Source: Source: 10-Q Cash Flow, p.1
Current liabilities increased by 46.5% year-over-year, which could pressure liquidity if not managed properly.
Source: Source: 10-Q Balance Sheet, p.1
Unlock 2 more detailed risk analysis
Upgrade to unlockReported EPS of $2.81 versus the $2.75 analyst consensus — a +2.1% beat for Q2 FY2026.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.42B | $1.28B | +10.98% |
Cost of Revenue | $544.08M | $530.81M | +2.50% |
Gross Profit | $878.72M | $751.27M | +16.96% |
Operating Income | $491.66M | $417.24M | +17.84% |
Net Income | $392.59M | $344.62M | +13.92% |
EPS (Basic) | $2.69 | $2.35 | +14.47% |
EPS (Diluted) | $2.68 | $2.34 | +14.53% |
R&D Expense | $90.97M | $81.37M | +11.79% |
SG&A Expense | $278.4M | $241.61M | +15.22% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $8.5B | $7.14B | +19.07% |
Current Assets | $3.82B | $2.84B | +34.65% |
Total Liabilities | $2.18B | $1.89B | +15.58% |
Current Liabilities | $1.25B | $851.96M | +46.50% |
Stockholders' Equity | $6.32B | $5.25B | +20.33% |
Cash & Equivalents | $1.42B | $521.94M | +171.50% |
Long-Term Debt | $403.92M | $662.86M | -39.06% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash FlowYTD | $797.07M | $634.16M | +25.69% |
Investing Cash FlowYTD | $-103.52M | $-34.55M | -199.66% |
Financing Cash FlowYTD | $-488.62M | $-298.3M | -63.81% |
Dividends PaidYTD | $175.33M | $155.59M | +12.69% |
Share BuybacksYTD | $325.02M | $124.99M | +160.04% |
D&A | $49.88M | $46.44M | +7.42% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 61.8% | 58.6% | +3.16% |
Operating Margin | 34.6% | 32.5% | +2.01% |
Net Margin | 27.6% | — | — |
ROE | 6.2% | — | — |
ROA | 4.6% | — | — |
Current Ratio | $3.06 | — | — |
Debt to Equity | $0.345 | — | — |
Other companies in Health Care Equipment
RMD reported a 14.5% increase in EPS (Diluted) to $2.68, indicating strong earnings performance, though specific estimates are not provided.
Key takeaways include an 11.0% revenue increase to $1.42 billion and a 13.9% rise in net income to $392.59 million, driven by strong market demand and operational efficiency.
RMD highlighted risks such as increased current liabilities by 46.5% and dependence on market demand, which could impact future performance.
RMD's revenue grew by 11.0% year-over-year to $1.42 billion, driven by strong demand in key markets.
RMD shows strong financial health with a current ratio of 3.06 and a significant increase in cash and equivalents by 171.5%.